Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2344 studies found for:    pancreatic cancer
Show Display Options
RSS Create an RSS feed from your search for:
pancreatic cancer
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Other: laboratory biomarker analysis
2 Completed
Has Results
Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Ipilimumab;   Biological: Pancreatic Cancer Vaccine
3 Completed Studying Biomarkers in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Genetic: protein analysis;   Other: laboratory biomarker analysis
4 Completed Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
5 Withdrawn Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: GAX - Gemcitabine, Abraxane and Xeloda
6 Terminated Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
7 Recruiting Exceptional Responders With Pancreatic Cancer to Chemotherapy
Condition: Pancreatic Neoplasms
Intervention: Drug: Standard of care chemotherapy
8 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
9 Withdrawn HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Procedure: interventional therapy
10 Completed A Phase III Study of Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
11 Unknown  Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
12 Recruiting Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab Trial for Surgically Resectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Cyclophosphamide;   Biological: GVAX pancreatic cancer;   Drug: Nivolumab
13 Enrolling by invitation Clinical Trial of Pancreatic Cancer in Stockholm.
Condition: Pancreatic Cancer
Intervention: Procedure: Pancreatic Surgery
14 Recruiting Pancreatic Cancer Genetics
Condition: Pancreatic Cancer
Intervention:
15 Active, not recruiting Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Biological: GVAX pancreatic cancer vaccine;   Drug: cyclophosphamide
16 Enrolling by invitation Electroporation (NanoKnife) as Treatment for Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Procedure: Electroporation/ Nano knife treatment;   Device: NanoKnife
17 Active, not recruiting Pancreatic Cancer Genetic Epidemiology (PACGENE) Study
Condition: Pancreatic Cancer
Intervention: Behavioral: Questionnaire
18 Recruiting BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Condition: Metastatic Pancreatic Cancer
Intervention: Drug: FOLFOXA
19 Completed
Has Results
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: RAD001
20 Recruiting Olaparib for BRCAness Phenotype in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Olaparib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.